Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells

被引:22
作者
Bokvist, K
Hoy, M
Buschard, K
Holst, JJ
Thomsen, MK
Gromada, J
机构
[1] Novo Nordisk AS, Islet Discovery Res, Dept Islet Cell Physiol, DK-2880 Bagsvaerd, Denmark
[2] Kommunehosp, Bartholin Inst, DK-1399 Copenhagen, Denmark
[3] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
关键词
exocytosis; glucagon; K-ATP channel; nateglinide; repaglinide;
D O I
10.1016/S0014-2999(99)00754-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of the two prandial glucose regulators, repaglinide and nateglinide, on ATP-sensitive K+ (K-ATP) channel activity, membrane potential and exocytosis in single rat pancreatic A-cells were investigated using the patch-clamp technique. K-ATP channel activity was reversibly blocked by repaglinide (K-d = 22 nM) and nateglinide (K-d = 410 nM) and this was associated with membrane depolarisation and initiation of electrical activity. The effect of repaglinide and nateglinide on stimulation of glucagon secretion by direct interference with the exocytotic machinery was investigated by the use of capacitance measurements. Nateglinide, but not repaglinide, at concentrations similar to those required to block K-ATP channels potentiated Ca2+-evoked exocytosis 3-fold. In alpha TC1-9 glucagonoma cells addition of nateglinide, but not repaglinide, was associated with stimulation of glucagon secretion. These results indicate that the fast-acting insulin secretagogue nateglinide is glucagonotropic primarily by stimulating Ca2+-dependent exocytosis. (C) 1999 Elsevier Science B.V. All lights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 34 条
[1]   CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION [J].
AGUILARBRYAN, L ;
NICHOLS, CG ;
WECHSLER, SW ;
CLEMENT, JP ;
BOYD, AE ;
GONZALEZ, G ;
HERRERASOSA, H ;
NGUY, K ;
BRYAN, J ;
NELSON, DA .
SCIENCE, 1995, 268 (5209) :423-426
[2]   ELECTROPHYSIOLOGY OF THE PANCREATIC BETA-CELL [J].
ASHCROFT, FM ;
RORSMAN, P .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1989, 54 (02) :87-143
[3]   The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic β cells is mediated by a 65-kDa mdr-like P-glycoprotein [J].
Barg, S ;
Renström, E ;
Berggren, PO ;
Bertorello, A ;
Bokvist, K ;
Braun, M ;
Eliasson, L ;
Holmes, WE ;
Köhler, M ;
Rorsman, P ;
Thévenod, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5539-5544
[4]   Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells [J].
Bokvist, K ;
Olsen, HL ;
Hoy, M ;
Gotfredsen, CF ;
Holmes, WF ;
Buschard, K ;
Rorsman, P ;
Gromada, J .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1999, 438 (04) :428-436
[5]   INTERNALIZATION OF GLIBENCLAMIDE-H-3 IN PANCREATIC-ISLET CELLS [J].
CARPENTIER, JL ;
SAWANO, F ;
RAVAZZOLA, M ;
MALAISSE, WJ .
DIABETOLOGIA, 1986, 29 (04) :259-261
[6]   MECHANISM OF INCREASED GLUCONEOGENESIS IN NONINSULIN-DEPENDENT DIABETES-MELLITUS - ROLE OF ALTERATIONS IN SYSTEMIC, HEPATIC, AND MUSCLE LACTATE AND ALANINE METABOLISM [J].
CONSOLI, A ;
NURJHAN, N ;
REILLY, JJ ;
BIER, DM ;
GERICH, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :2038-2045
[7]   PATHOGENESIS OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - A BALANCED OVERVIEW [J].
DEFRONZO, RA .
DIABETOLOGIA, 1992, 35 (04) :389-397
[8]   EFFECT OF GLUCOSE-SULFONYLUREA INTERACTION ON RELEASE OF INSULIN, GLUCAGON, AND SOMATOSTATIN FROM ISOLATED PERFUSED RAT PANCREAS [J].
EFENDIC, S ;
ENZMANN, F ;
NYLEN, A ;
UVNASWALLENSTEN, K ;
LUFT, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5901-5904
[9]   PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells [J].
Eliasson, L ;
Renstrom, E ;
Ammala, C ;
Berggren, PO ;
Bertorello, AM ;
Bokvist, K ;
Chibalin, A ;
Deeney, JT ;
Flatt, PR ;
Gabel, J ;
Gromada, J ;
Larsson, O ;
Lindstrom, P ;
Rhodes, CJ ;
Rorsman, P .
SCIENCE, 1996, 271 (5250) :813-815
[10]  
FLATT PR, 1994, DIABETES METAB, V20, P157